Bacillus anthracis: balancing innocent research with dual-use potential
- PMID: 18375178
- PMCID: PMC7106442
- DOI: 10.1016/j.ijmm.2007.09.007
Bacillus anthracis: balancing innocent research with dual-use potential
Abstract
Anthrax Euronet, a Coordination Action of the EU 6th Framework Programme, was designed to strengthen networking activities between anthrax research groups in Europe and to harmonise protocols for testing anthrax vaccines and therapeutics. Inevitably, the project also addressed aspects of the current political issues of biosecurity and dual-use research, i.e. research into agents of important diseases of man, livestock or agriculture that could be used as agents of bioterrorism. This review provides a comprehensive overview of the biology of Bacillus anthracis, of the pathogenesis, epidemiology and diagnosis of anthrax, as well as vaccine and therapeutic intervention strategies. The proposed requirement for a code of conduct for working with dual-use agents such as the anthrax bacillus is also discussed.
Figures
References
-
- Abrami L., Reig N., van der Goot F.G. Anthrax toxin: the long and winding road that leads to the kill. Trends Microbiol. 2005;13:72–78. - PubMed
-
- Baillie L.W.J. Past, imminent and future human medical countermeasures for anthrax. J. Appl. Microbiol. 2006;101:594–606. - PubMed
-
- Baldari C.T., Tonello F., Paccani S.R., Montecucco C. Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol. 2006;27:434–440. - PubMed
-
- Beyer W. Vaccination strategies for anthrax prevention. Berl. Münch. Tierarztl. Wochenschr. 2004;117:508–524. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
